Navegar por autor "Bernabeu Morón, Ignacio"

Adenomas hipofisarios funcionantes

2012- Fernández Rodríguez, Eva; Bernabeu Morón, Ignacio; Casanueva Freijo, Felipe

Adrenal carcinoma: a retrospective analysis of our series

2013- Cameselle Teijeiro, Jose Manuel; Bernabeu Morón, Ignacio; Andujar Plata, Paula; Casanueva Freijo, Felipe; Cabezas Agrícola, José Manuel; [et al.]

Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments

2015- Bernabeu Morón, Ignacio; Quinteiro García, Celsa

Cabergoline treatment in acromegaly: pros

2014- Marazuela, M; Ramos-Levi, A; Sampedro-Nunez, M; Bernabeu Morón, Ignacio

Changes in acromegaly treatment over four decades in Spain: Analysis of the Spanish Acromegaly Registry (REA)

2013- Bernabeu Morón, Ignacio

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

2011- Bernabeu Morón, Ignacio

Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey

2019- de Pablos-Velasco, P.; Venegas, E. M.; Álvarez Escolá, C.; Fajardo, C.; de Miguel, P.; [et al.]

Diagnóstico y tratamiento del incidentaloma hipofisario

2012- Abal Arca, José; Fernández Rodríguez, Eva; Bernabeu Morón, Ignacio; Andujar Plata, Paula

Disorders of the neurohypophysis

2012- Fernández Rodríguez, Eva; Bernabeu Morón, Ignacio; Casanueva Freijo, Felipe

Documento de consenso del área de conocimiento de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición para el abordaje del hipopituitarismo durante la transición

2014- Fernández Rodríguez, Eva; Bernabeu Morón, Ignacio

Effectiveness of lanreotide autogel 120?mg at extended dosing intervals for acromegaly

2020- Bernabeu Morón, Ignacio; Fajardo, Carmen; Marazuela, Mónica; CORDIDO CARBALLIDO, FERNANDO; Venegas, Eva María; [et al.]

Epidemiologic features and predictors of mortality in a cohort of adult patients with hypopituitarism

2011- Fernández Rodríguez, Eva; Bernabeu Morón, Ignacio; Casanueva Freijo, Felipe

Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients

2013- Fernández Rodríguez, Eva; Bernabeu Morón, Ignacio; Andujar Plata, Paula; Casanueva Freijo, Felipe

Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study

2014- Bernabeu Morón, Ignacio

Estudio clinico y molecular de cinco familias con resistencia a la accion de las hormonas tiroideas.

2011- Peteiro Gonzalez, Diego; Bernabeu Morón, Ignacio; Araujo Vilar, David; Peinó García, Roberto

Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: Tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type

2011- Bernabeu Morón, Ignacio; Loidi Fernández, Lourdes; Pombo Arias, Manuel; Cabanas Rodríguez, Paloma; Castro Feijoo, Lidia; [et al.]

Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues

2013- Bernabeu Morón, Ignacio

GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

2020- Pradilla Dieste, A.; Chenlo, M.; Perez-Romero, S.; Garcia-Rendueles, ÁR; Suarez-Fariña, M.; [et al.]

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas

2011- Bernabeu Morón, Ignacio

Hypopituitarism following traumatic brain injury: determining factors for diagnosis.

2011- Fernández Rodríguez, Eva; Bernabeu Morón, Ignacio; Casanueva Freijo, Felipe; Castro Pais, Ana Isabel

Repositorio digital RUNA

Navegar por autor "Bernabeu Morón, Ignacio"

Adenomas hipofisarios funcionantes ﻿

Adrenal carcinoma: a retrospective analysis of our series ﻿

Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments ﻿

Cabergoline treatment in acromegaly: pros ﻿

Changes in acromegaly treatment over four decades in Spain: Analysis of the Spanish Acromegaly Registry (REA) ﻿

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone. ﻿

Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey ﻿

Diagnóstico y tratamiento del incidentaloma hipofisario ﻿

Disorders of the neurohypophysis ﻿

Documento de consenso del área de conocimiento de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición para el abordaje del hipopituitarismo durante la transición ﻿

Effectiveness of lanreotide autogel 120?mg at extended dosing intervals for acromegaly ﻿

Epidemiologic features and predictors of mortality in a cohort of adult patients with hypopituitarism ﻿

Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients ﻿

Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study ﻿

Estudio clinico y molecular de cinco familias con resistencia a la accion de las hormonas tiroideas. ﻿

Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: Tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type ﻿

Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues ﻿

GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells ﻿

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas ﻿

Hypopituitarism following traumatic brain injury: determining factors for diagnosis. ﻿

Adenomas hipofisarios funcionantes

Adrenal carcinoma: a retrospective analysis of our series

Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments

Cabergoline treatment in acromegaly: pros

Changes in acromegaly treatment over four decades in Spain: Analysis of the Spanish Acromegaly Registry (REA)

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey

Diagnóstico y tratamiento del incidentaloma hipofisario

Disorders of the neurohypophysis

Documento de consenso del área de conocimiento de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición para el abordaje del hipopituitarismo durante la transición

Effectiveness of lanreotide autogel 120?mg at extended dosing intervals for acromegaly

Epidemiologic features and predictors of mortality in a cohort of adult patients with hypopituitarism

Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients

Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study

Estudio clinico y molecular de cinco familias con resistencia a la accion de las hormonas tiroideas.

Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: Tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type

Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues

GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas

Hypopituitarism following traumatic brain injury: determining factors for diagnosis.